about
Biological Therapy in Treating Patients With Primary or Advanced GliomaPembrolizumab in Advanced BRCA-mutated Breast CancerMetronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid TumoursAvelumab With Chemoradiation for Stage II/III Resectable Esophageal CancerPegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerGenetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ MalignanciesImage Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney CancerZIKAlliance Natural History StudyAlisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast CancerRepeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic AstrocytomaA Pilot Study Treatment of Malignant Tumors Using [18F] Fluorodeoxyglucose (FDG)Effect of Mental Imagery Training on Brain Plasticity and Motor Function in Individuals With Parkinson's DiseasePatients With Relapsed Ovarian Cancer (2nd and 3rd Line) Treated With Chemotherapy According to AGO GuidelinesCognitive Behavioral Therapy, Modafinil, or Both for Multiple Sclerosis FatiguePC4PrEP: Integrating PrEP Into Primary CareFecal Microbiota Transplantation for C. Difficile Infection in Solid Organ Transplant RecipientsBRAVO - Betrixaban Registry Using Real Time Observations in Acute Medical Illness to Assess Venous Thrombosis and Bleeding OutcomesRole of the Gut Microbiome in Complex Regional Pain SyndromeSafety and Efficacy of Dapagliflozin in Asian T2DM Subjects With Inadequate Glycemic Control on Metformin/SaxagliptinNovel Approach for the Prevention of Hypoglycemia Associated Autonomic Failure (HAAF)The January Application NUtritional Study (JANUS)Effectiveness of Modified Constraint Induced Movement Therapy to Improve Lower Extremity Function in the Acute and Subacute Stroke Patients by Providing 1 Hour of Intense Massed Practice in the Form of Shaping or Task PracticeA Psychoeducational Intervention Supporting Patients With an Inherited Cardiac ConditionPacritinib in Relapsed/Refractory Lymphoproliferative DisordersAlpelisib in Treating Participants With Transorally Resectable HPV-Associated Stage I-IVA Oropharyngeal CancerImplementation and Validation of Telemedicine Software for the Automation of MRI Examinations of Acute Myocardial InfarctionspTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate CancerThe STOP-HPV Trial 3: Prompts InterventionONES Grant: CXCL10/CXCR3 Regulation of Ozone-Induced Epithelial PermeabilityInpatient ICOUGH RECOVERY App Version 2.0Hypertension ChronobiomeTest and Evaluation of Non-Invasive Neuro-Assessment Devices (NINAD): NeuroKinetics, Inc, iPASSULTAN (Improving SUrgery of Liver Metastases: a Trial of the Arterial Chemotherapy Network)Propranolol Hydrochloride in Treating Patients With Prostate Cancer Undergoing SurgeryExamination of Differential Valuation of Leisure Items and Attention as Reinforcers in Children With AutismHigh Intensity Focused Ultrasound Tumor Treatment for Pancreatic Cancer PainAntipsychotics and Metabolic SyndromePercutaneous Vertebroplasty: Prophylactic Treatment of Adjacent VertebraMucomyst for Hepatitis CThe Chinese Mutation Hotspot of ENaC Causing Liddle's Syndrome and the Association of ENaC Variations and Hypertension
P8005
Q58407318-047084B1-4C8D-4892-9CAC-C3A5968F04B3Q58407318-AEB561A7-5C48-47F0-995F-0D29F9C4CE8AQ58407726-DE432380-6B77-4EB9-B31F-53D86D3454CBQ58407796-2CF42644-C608-4762-8C2C-81B31C794FACQ58407817-1628CA08-8A9C-44DB-A2BC-9AB278AEA40BQ58845627-3BC1A787-BC5B-4709-A8ED-798E14B8AFCFQ58849869-0EF509CE-F14C-4EA5-A0BD-274A243184EFQ58849945-C8DA573F-D8AD-47C4-840F-602093692568Q60563338-068BC2DA-5C45-428C-9439-D041B8EC60B7Q61862149-18C270AC-135F-4705-8365-A1C779D3D79BQ61864902-4E8EAB55-8A37-483A-9773-DC31BE693FB9Q61894396-420BBB43-7048-4E3A-9571-90E7CB5E13F9Q61902397-FE49AF0D-76C0-4729-86D2-3FAD95A2EEB5Q61902441-6D0AB7B9-F101-44C1-A0FC-80523E7D8481Q61902441-9ED3A143-192A-4BF4-8697-9D3449DAAAAEQ61902550-55F54913-48A4-4ED9-97CA-A70C4E467F9BQ61904709-39B143BC-5D10-46D7-BEEE-2F11C6E9C78EQ61904757-A7733263-D82F-43E5-B935-E625594CCFD0Q61905076-3813430A-A7F1-46F9-900D-F0F7899559C1Q61906719-864BA41E-9DAD-4808-8699-AD8B814780DCQ61907055-6DF5BDFD-63B3-427C-B713-BFB0EF399071Q61907071-14381AF5-8C9A-4DE4-BFB1-51657C3CD529Q61907417-A1CAD1B3-E105-4796-8CC4-F63ACEFDF3C1Q61907433-29EF7292-7993-4307-A8E6-45EA05B83901Q61907582-22AD8632-169F-4E83-BAB4-19041B06A9DCQ61907598-9F12A3BD-026E-41B0-ADBD-2446A925D9C2Q61907623-3DB3F8B1-3D23-4CE6-A0E9-131383AE7AF1Q61907623-569451AA-0C03-4619-B81C-6828B25CA219Q61907625-1D9CA6F0-E0A9-4E2B-8DDE-3B93025DC7DFQ61907625-DF529CC2-B5E6-4BDF-9B38-CE9CA574EEFCQ61907717-7FB18980-174A-4DE5-A710-38A4208AF176Q61907792-F351168D-33B8-4BB3-B6B7-0B770C643F54Q61907819-4F9574DC-79FF-48E7-BCDF-5AA47CCC7C72Q61907840-0F7A2028-67B0-4781-9ADF-C75A2B9AC0ADQ61907852-A9C774D9-DAC2-4452-BC08-027F31A96BBCQ61908750-7329ACFF-6100-4852-B416-60C8F78E90ECQ61908883-4E6E3E0B-9836-4411-9C2B-440B11944557Q61908883-EA4B7656-2A2A-4D84-B564-60850539D122Q61909879-9EB01082-A1D7-46CA-9874-22F56C69C705Q61909912-0FCE1199-B0B8-486F-BF67-6DE5DE20C573
P8005
description
recruitment status in clinical trials
@en
name
suspended
@en
suspès
@ca
type
label
suspended
@en
suspès
@ca
prefLabel
suspended
@en
suspès
@ca